(Q39369078)

11 September 2017

title

Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation (English)

1 reference

11 September 2017

0 references

1 reference

Abbas K Samadi

1

1 reference

11 September 2017

Stephanie M Cohen

2

1 reference

11 September 2017

Ridhwi Mukerji

3

1 reference

11 September 2017

Vamsee Chaguturu

4

1 reference

11 September 2017

Xuan Zhang

5

1 reference

11 September 2017

Barbara N Timmermann

6

1 reference

11 September 2017

Mark S Cohen

7

1 reference

11 September 2017

Erica A Person

8

1 reference

11 September 2017

language of work or name

1 reference

5 April 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

33

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

1179-1189

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-012-0363-x

11 September 2017

exact match

0 references

cites work

Metastatic uveal melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Uveal melanoma: genetic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Endoplasmic reticulum stress mediates withaferin A-induced apoptosis in human renal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Withaferin A, a Cytotoxic Steroid from Vassobia breviflora, Induces Apoptosis in Human Head and Neck Squamous Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

A novel HSP90 modulator with selective activity against thyroid cancers in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

The RAS-BRAF kinase pathway is not involved in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Genetics of uveal melanoma and cutaneous melanoma: two of a kind?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Extracellular signal-regulated kinase-dependent proliferation is mediated through the protein kinase A/B-Raf pathway in human uveal melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

New insight into BRAF mutations in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

21 January 2018

Main roads to melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Oncogenic mutations in GNAQ occur early in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Targeting the c-Met signaling pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Frequent mutation of BAP1 in metastasizing uveal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

MET oncogene inhibition as a potential target of therapy for uveal melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0363-X

Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF)

21 January 2018

1 reference

12 December 2020

Immunohistochemical expression of phospho-Akt in uveal melanoma

1 reference

12 December 2020

Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications

1 reference

12 December 2020

Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study

1 reference

12 December 2020

Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review

1 reference

12 December 2020

G1 phase arrest by the phosphatidylinositol 3-kinase inhibitor LY 294002 is correlated to up-regulation of p27Kip1 and inhibition of G1 CDKs in choroidal melanoma cells

1 reference

12 December 2020

Absence of BRAF and NRAS mutations in uveal melanoma

1 reference

12 December 2020

Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells

1 reference

12 December 2020

Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.

1 reference

12 December 2020

10.1007/S13277-012-0363-X

Identifiers

DOI

1 reference

11 September 2017

1 reference